Chinese Journal of Pharmacovigilance ›› 2019, Vol. 16 ›› Issue (5): 319-320.
CHEN Qiaohui, CHEN Dezhi, XU Yanyu, CHEN Zhimin*
Received:2018-01-16
Revised:2019-06-11
Online:2019-05-20
Published:2019-06-11
CLC Number:
CHEN Qiaohui, CHEN Dezhi, XU Yanyu, CHEN Zhimin. One Case of Large Area Skin Rash Induced by Alanyl Glutamine Injection[J]. Chinese Journal of Pharmacovigilance, 2019, 16(5): 319-320.
Add to citation manager EndNote|Ris|BibTeX
| [1] 魏晶,王瑜歆.药品不良反应报告因果关系评价方法概述[J]. 中国药物警戒,2011,8(10):600-602. [2] 陈集志,万平.丙氨酰谷氨酰胺注射液致肝损害伴药疹1例[J]. 中国药师,2014,17(8):1375-1376. [3] 黄静. 14例丙氨酰谷氨酰胺注射液不良反应的文献分析[J]. 海峡药学,2017,29(3):270-271. [4] 杨香瑜,张韶辉,郭珩,等.丙氨酰谷氨酰胺注射液临床应用分析及合理性探讨[J]. 中南药学,2017,15(9):1338-1340. [5] 徐雪梅,王如伟.注射用丙氨酰谷氨酰胺的安全性评价[J]. 中国热带医学,2009,12(9):2313-2314. [6] 王晶,左小霞,张晔.谷氨酰胺临床应用研究进展[J]. 人民军医,2013,56(4):469-470. [7] 刘颖,周海霞,汪晓东,等.丙氨酰-谷氨酰胺二肽临床研究进展[J]. 华西医学,2010,25(7):1382-1384. [8] 曾婷. 丙氨酰谷氨酰胺不合理使用引发的不良反应情况分析[J]. 临床合理用药,2017,10(4C):39-41. [9] 鄢秀英. 静脉滴注丙氨酰谷氨酰胺致过敏反应一例[J]. 华西医学,2012,27(8):1280. [10] 李魏嶙,秦维春.26例丙氨酰谷氨酰胺注射液不良反应分析[J]. 临床合理用药, 2017,10(2C):101-102. [11] 邓永平,杨怀勇.静滴丙氨酰谷氨酰胺致过敏性休克1例[J]. 中外妇儿健康,2011,19(6):285. [12] 张敏娟,徐贞.关于丙氨酰谷氨酰胺注射液的不合理用药分析[J]. 实用药物与临床,2014,17(4):476-477. [13] 周燕萍,龚茜芬,王自强.丙氨酰谷氨酰胺双肽在胃肠道术后应用的安全性和有效性观察[J]. 中国药房,2005,16(17):1321-1323. |
| [1] | LI Xinying, BAO Lei, LI Shuran, ZHAO Ronghua, SUN Jing, XIE Dan, BAO Yanyan, GUO Shanshan, CUI Xiaolan, GENG Zihan. Effect of Shufeng Jiedu Capsules on the Production of Specific Antibodies against Influenza A H1N1 Virus and the Mechanisms [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 841-850. |
| [2] | WANG Xinwei, PENG Yifeng, SUN Jing, JI Zuen, BAO Lei, LUO Henglei, GENG Zihan, ZHANG Hujuan, LI Shuran, ZHANG Jingsheng, GUO Shanshan, CUI Xiaolan, ZHAO Ronghua. Effect of Yiye Anti-Influenza Capsules on Pneumonia Induced by Human Coronavirus 229E Infection in Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 851-855. |
| [3] | XIE Rui, SUN Qiyue, LI Yanying, ZHANG Jingsheng, ZHAO Ronghua, GUO Shanshan, GENG Zihan, BAO Lei, GAO Shuangrong, CUI Xiaolan, XIE Dan, SUN Jing. Impacts of Shuangshenling Granules on a Cadmium-Induced Chronic Renal Failure Model of Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 856-862. |
| [4] | CHEN Siying, DING Xueli, LIU Shujia, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian. Modeling for Prediction of Cardiotoxicity of Chinese Herbal Medicines [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 869-875. |
| [5] | CAI Haili, ZHANG Xiaomeng, LIU Yadi, CHEN Lijuan, WANG Yu, ZHANG Bing. Preventive Strategies for Anthracycline-Induced Cardiotoxicity Using Traditional Chinese Medicine via Ferroptosis Regulation [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 876-882. |
| [6] | ZHENG Haiyun, WANG Zhigang, WU Hongwei, WANG Shaonan, WANG Bin. Identification of in vitro and in vivo Chemical Constituents of Buxin Anmian Decoction Based on UPLC-Q Exactive Orbitrap HRMS [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 883-888. |
| [7] | SUN Ya, WANG Xu, SUN Zhi, ZHOU Yubing. Dose Analysis of Linezolid in Severe Patients with Sepsis Complicated with Acute Kidney Injury [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 889-895. |
| [8] | SHI Qi, WANG Jianxin, WANG Guijie, LU Yueyang, ZHU Jiaxu, GAO Rui. Adjuvant Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Qingqi Huatan Pills: a Systematic Review [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 914-919. |
| [9] | YING Jie, XU Xiaolong, LI Bo, LIU Tengwen, LIU Qingquan. Clinical Applications of Jinhua Qinggan Granules in the Treatment of Mild Influenza: a Meta-Analysis [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 920-923. |
| [10] | KE Xiuqin, HAI Xuewu. 433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927. |
| [11] | LIANG Jie. 172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932. |
| [12] | LIU Jiang, CHEN Jie, QIU Sihong, LI Na, ZHOU Ying, CHEN Yonggang, LUO Ji. Analysis of Adverse Drug Event Induced by Omacycline and Moxifloxacin Based on FAERS Databse [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 933-936. |
| [13] | ZHAO Mudan, ZHU Minghui, ZHANG Huan, ZHAO Yuanyang, QIN Jing. Pharmaceutical Care of a Case of Diabetic Foot Infection Caused by Proteus penneri [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 937-940. |
| [14] | ZHOU Yujie, HUANG Xiaojing, CHEN Mingyue, DU Pengqiang, WANG Aifeng. Two Cases of Severe Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 941-943. |
| [15] | CHEN Huabao, LIU Wei, JIANG Ting, ZHENG Lingli, LI Jing. One Case of Acute Withdrawal Syndrome Caused by Naloxone [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 944-946. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
